Provider of bio-pharmaceutical services. The company's bio-pharmaceutical services focuses on developing products to treat cancer, infectious diseases and other medical conditions associated with compromised immune systems, enabling cancer patients to get cure of malignant tumors and uncontrolled cell division.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Intertech Bio‘s full profile, request access.
Request a free trial